Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Journal of Diabetes and Metabolic Disorders|November 29, 2024
Precision medicine path at personalized medicine research center/endocrinology and metabolism research institute: A systematic reviewNegar Sarhangi, Shekoufeh Nikfar, Mandana Hasanzad, et al.Journal of Diabetes and Metabolic Disorders|June 8, 2022
Artificial intelligence perspective in the future of endocrine diseasesMandana Hasanzad, Hamid Reza Aghaei Meybodi, Negar Sarhangi, et al.Journal of Diabetes and Metabolic Disorders|December 13, 2021
The role of the PPARG (Pro12Ala) common genetic variant on type 2 diabetes mellitus riskLeila Hashemian, Negar Sarhangi, Mahdi Afshari, et al.Medical Hypothesis, Discovery & Innovation Ophthalmology Journal|January 26, 2018
The Role of Mitochondrial DNA (mtDNA) in the Development of Diabetic Retinopathy (DR): A Systematic ReviewNegar Sarhangi, Fatemeh Khatami, Abbasali Keshtkar, et al.Journal of Diabetes and Metabolic Disorders|December 13, 2021
A pharmacogenetic pilot study of <i>CYP2C9</i> common genetic variant and sulfonylureas therapeutic response in type 2 diabetes mellitus patientsElham Didari, Negar Sarhangi, Mahdi Afshari, et al.Journal of Diabetes and Metabolic Disorders|June 8, 2022
Influence of cytotoxic T lymphocyte antigen 4 genetic variants on acute rejection in kidney transplant patients: precision medicine perspectiveAndia Taleb, Mahdi Afshari, Mohammad Samzadeh, et al.Journal of Diabetes and Metabolic Disorders|December 13, 2021
Pilot study in pharmacogenomic management of empagliflozin in type 2 diabetes mellitus patientsMahdieh Jamalizadeh, Mandana Hasanzad, Negar Sarhangi, et al.Molecular Biology Reports|June 22, 2022
Breast cancer in the era of precision medicineNegar Sarhangi, Shahrzad Hajjari, Seyede Fatemeh Heydari, et al.The Pharmacogenomics Journal|September 19, 2023
Using ChatGPT to predict the future of personalized medicineGeorge P Patrinos, Negar Sarhangi, Behnaz Sarrami, et al.Journal of Diabetes and Metabolic Disorders|February 1, 2021
A narrative review of current trends in liraglutide: insights into the unmet needs in management of type 2 diabetes and obesityMandana Hasanzad, Negar Sarhangi, Shekoufeh Nikfar, et al.Pageof 3